CA Patent

CA2391076A1 — Solutions containing epinastin

Assigned to Boehringer Ingelheim International GmbH · Expires 2001-05-25 · 25y expired

What this patent protects

The invention relates to topically administered aqueous solutions containing epinastin, optionally in the form of its racemate or its enantiomers and optionally in the form of the pharmacologically acceptable acid addition salts thereof.

USPTO Abstract

The invention relates to topically administered aqueous solutions containing epinastin, optionally in the form of its racemate or its enantiomers and optionally in the form of the pharmacologically acceptable acid addition salts thereof.

Drugs covered by this patent

olopatadine-hydrochloride (OLOPATADINE HYDROCHLORIDE)

Patent Metadata

Patent number: CA2391076A1
Jurisdiction: CA
Classification: —
Expires: 2001-05-25
Drug substance claim: No
Drug product claim: No
Assignee: Boehringer Ingelheim International GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.